These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2457945)

  • 1. [Research on receptors of calcium antagonists and the calcium channel].
    Zhang HL
    Sheng Li Ke Xue Jin Zhan; 1988 Apr; 19(2):155-60. PubMed ID: 2457945
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual roles for DHP receptors in excitation--contraction coupling?
    Agnew WS
    Nature; 1987 Jul 23-29; 328(6128):297. PubMed ID: 3037386
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphatidylinositol turnover as a functional probe for neuronal Ca2+ channels.
    Zernig G; Moshammer T; Glossmann H
    Prog Clin Biol Res; 1988; 252():41-5. PubMed ID: 2450375
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects.
    Snyder SH; Reynolds IJ
    N Engl J Med; 1985 Oct; 313(16):995-1002. PubMed ID: 2413355
    [No Abstract]   [Full Text] [Related]  

  • 5. Signals to and from the nicotinic acetylcholine receptor.
    Raftery M
    Alcohol Drug Res; 1985-1986; 6(2-3):69-71. PubMed ID: 2418849
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular properties of voltage-sensitive calcium channels.
    Catterall WA; Curtis BM
    Soc Gen Physiol Ser; 1987; 41():201-13. PubMed ID: 2436311
    [No Abstract]   [Full Text] [Related]  

  • 7. Conformational features of calcium channel agonist and antagonist analogs of nifedipine.
    Langs DA; Triggle DJ
    Mol Pharmacol; 1985 May; 27(5):544-8. PubMed ID: 2581123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium channels and calcium antagonists].
    Imai S
    Tanpakushitsu Kakusan Koso; 1988 Sep; 33(12):1862-76. PubMed ID: 2855995
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium antagonist receptors. Clinical and physiological relevance.
    Wagner JA; Guggino SE; Reynolds IJ; Snowman AM; Biswas A; Olivera BM; Snyder SH
    Ann N Y Acad Sci; 1988; 522():116-33. PubMed ID: 2454047
    [No Abstract]   [Full Text] [Related]  

  • 10. Excitation-contraction coupling. Proteins that bridge the gap.
    Agnew WS
    Nature; 1988 Jul; 334(6180):299-300. PubMed ID: 2455870
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular properties of dihydropyridine-sensitive calcium channels.
    Seagar MJ; Takahashi M; Catterall WA
    Ann N Y Acad Sci; 1988; 522():162-75. PubMed ID: 2454051
    [No Abstract]   [Full Text] [Related]  

  • 12. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.
    Triggle DJ; Janis RA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proof of the existence of receptor-dependent calcium channels in blood platelets].
    Avdonin PV; Bugriĭ EM; Cheglakov IB; Mazaev AV; Tkachuk VA
    Dokl Akad Nauk SSSR; 1986; 289(1):220-4. PubMed ID: 2426070
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers].
    Kitamura K; Ogata R
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
    Glossmann H; Ferry DR; Goll A; Rombusch M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the drug receptors of the purified skeletal muscle calcium channel.
    Striessnig J; Glossmann H
    Prog Clin Biol Res; 1988; 252():35-40. PubMed ID: 2450374
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential sensitivity of calcium channels to dihydropyridines. The modulated receptor hypothesis.
    Chin JH
    Biochem Pharmacol; 1986 Dec; 35(23):4115-20. PubMed ID: 2431688
    [No Abstract]   [Full Text] [Related]  

  • 18. [Calcium channels, calcium pumps and calcium antagonists].
    Schaub MC
    Schweiz Rundsch Med Prax; 1987 Feb; 76(7):165-70. PubMed ID: 2437636
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of calcium and L-type channels in nicotine-induced antinociception.
    Damaj MI; Welch SP; Martin BR
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1330-8. PubMed ID: 7690401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium antagonists, calcium entry blockers and calcium overload blockers; nomenclature and classification].
    van Zwieten PA
    Ned Tijdschr Geneeskd; 1985 Apr; 129(17):777-80. PubMed ID: 2582280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.